Market revenue in 2022 | USD 76.9 million |
Market revenue in 2030 | USD 163.1 million |
Growth rate | 9.9% (CAGR from 2022 to 2030) |
Largest segment | Evaporative dry eye syndrome |
Fastest growing segment | Evaporative Dry Eye Syndrome |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Evaporative Dry Eye Syndrome, Aqueous Deficient Dry Eye Syndrome |
Key market players worldwide | Novartis AG ADR, AbbVie Inc, Sun Pharmaceutical Industries, Santen Pharmaceutical Co Ltd, Johnson & Johnson, Otsuka Pharmaceutical, OASIS Medical, Bausch & Lomb Corp, AFT Pharmaceuticals, Oyster Point Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dry eye syndrome treatment market will help companies and investors design strategic landscapes.
Evaporative dry eye syndrome was the largest segment with a revenue share of 82.44% in 2022. Horizon Databook has segmented the Australia dry eye syndrome treatment market based on evaporative dry eye syndrome, aqueous deficient dry eye syndrome covering the revenue growth of each sub-segment from 2018 to 2030.
Dry eye syndrome affects one-third of Australian adults and half of those over the age of 50 and women are expected to be at a higher risk of developing the disease. According to Optometry Australia report in January 2020, it was estimated that 77% of Australians suffer from dry eye, however, only 26% had consulted an optometrist to learn about the latest treatment options.
Therefore, the prevalence of dry eye disease in Australians is likely to be severely underestimated. Moreover, as the pediatric population encounters signs and symptoms of dry eye as a result of increasing screen usage, the incidence of this condition is anticipated to rise in the future. This high patient burden is likely to boost demand for effective therapeutics to treat dry eye disease in the region.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia dry eye syndrome treatment market , including forecasts for subscribers. This country databook contains high-level insights into Australia dry eye syndrome treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account